# US 2021/0164006 A1 · Materials and Methods for Producing Alkaloids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0164006 A1
- Document ID: US20210164006A1
- Status: Published application
- Kind: A1
- Application number: 16/956,476
- Filed: 2018-12-21
- Published: 2021-06-03
- Earliest claimed: 2017-12-21
- Assignees: Biotelliga Holdings Limited
- Applicants: Biotelliga Holdings Limited
- Inventors: Damien James FLEETWOOD; Mikhail FOKIN; Kelly Alexander STYLES; Amritha Suhasini WICKRAMAGE; Sanjay SAIKIA
- Web page: https://patentgrep.com/patent/US20210164006A1

## CPC

- A01N 43/90: having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- C12N 9/16: acting on ester bonds (3.1)
- C07K 14/37: from fungi
- C07K 14/385: from Penicillium
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12N 9/1085: {transferring alkyl or aryl groups other than methyl groups (2.5)}
- C12N 9/80: acting on amide bonds in linear amides {(3.5.1)}
- C12N 15/80: for fungi
- C12P 17/188: {Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms (ergot-alcaloids C12P17/183)}
- C12Y 205/01: transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The invention generally relates to methods of producing loline alkaloids or precursors thereof, expression constructs, and host cells useful for producing loline alkaloids or precursors thereof, and methods for producing loline alkaloids or precursors thereof in a host cell.

## Claims

### Claim 20

A host cell able to produce more of at least one loline alkaloid or precursor thereof, than does a control cell, as a result of the host cell being transformed or modified to comprise at least one polynucleotide selected from the group consisting of:
i) a polynucleotide encoding a polypeptide comprising the sequence of any one of SEQ ID NO:1, 12, 13 and 61 or a variant thereof with at least 40% identity to any one of SEQ ID NO:1, 12, 13 and 61 with at least one of activity of a gamma-class PLP enzyme and an activity substantially equivalent to that of a lolC gene product,
ii) a polynucleotide encoding a polypeptide comprising the sequence of any one of SEQ ID NO:2, 14, 15 and 62 or a variant thereof with at least 40% identity to any one of SEQ ID NO:2, 14, 15 and 62 with at least one of activity of an alpha-class PLP enzyme and activity substantially equivalent to that of the lolD gene product,
iii) a polynucleotide encoding a polypeptide comprising the sequence of any one of SEQ ID NO:3, 16, 17 and 63 or a variant thereof with at least 40% identity to of any one of SEQ ID NO:3, 16, 17 and 63 with at least one of monooxygenase activity and activity substantially equivalent to that of the lolF gene product, iv) a polynucleotide encoding a polypeptide comprising the sequence of any one of SEQ ID NO:4, 18 and 19 or a variant thereof with at least 40% identity of any one of SEQ ID NO:4, 18 and 19 with at least one of amino acid bridging activity and activity substantially equivalent to that of the lolA gene product,
v) a polynucleotide encoding a polypeptide comprising the sequence of any one of SEQ ID NO:5, 20, 21 and 64 or a variant thereof with at least 40% identity to of any one of SEQ ID NO:5, 20, 21 and 64 with at least one of activity of an alpha-class PLP enzyme and activity substantially equivalent to that of the lolT gene product,
vi) a polynucleotide encoding a polypeptide comprising the sequence of of any one of SEQ ID NO:6, 22, 23 and 65 or a variant thereof with at least 40% identity to of any one of SEQ ID NO:6, 22, 23 and 65 with at least one of activity of a non-heme iron dioxygenase and activity substantially equivalent to that of the lolE gene product,
vii) a polynucleotide encoding a polypeptide comprising the sequence of any one of SEQ ID NO:7, 24, 25 and 66 or a variant thereof with at least 40% identity to any one of SEQ ID NO:7, 24, 25 and 66 with at least one of activity of a non-heme iron dioxygenase and activity substantially equivalent to that of the lolO gene product,
viii) a polynucleotide encoding a polypeptide comprising the sequence of any one of SEQ ID NO:8, 26 and 27 or a variant thereof with at least 40% identity to any one of SEQ ID NO:8, 26 and 27 with activity substantially equivalent to that of the lolU gene product,
ix) a polynucleotide encoding a polypeptide comprising the sequence of SEQ ID NO:9 or 28 or a variant thereof with at least 40% identity to SEQ ID NO:9 or 28 with at least one of N-Methyltransferase activity and activity substantially equivalent to that of the lolM gene product,
x) a polynucleotide encoding a polypeptide comprising the sequence of any one of SEQ ID NO:10, 29 and 67 or a variant thereof with at least 40% identity to any one of SEQ ID NO:10, 29 and 67 with at least one of acetamidase activity and activity substantially equivalent to that of the lolN gene product, and
xi) a polynucleotide encoding a polypeptide comprising the sequence of SEQ ID NO:11 or 30 or a variant thereof with at least 40% identity to SEQ ID NO:11 or 30 with at least one of cytochrome P450 monooxygenase activity and activity substantially equivalent to that of the lolP gene product.

### Claim 21 (depends on 20)

The host cell of claim 20 wherein the host cell is able to produce more of at least one loline alkaloid, than does a control cell, as a result of the host cell being transformed or modified to comprise the at least one polynucleotide.

### Claim 22 (depends on 20)

The host cell of claim 20 wherein the host cell is tolerant of endogenous (3-amino-3-carboxypropyl) proline (ACPP) production.

### Claim 23 (depends on 22)

The host cell of claim 22 wherein the host cell has been pre-selected for tolerance to cellular ACPP.

### Claim 24 (depends on 20)

The host cell of claim 20 wherein the host cell prior to modification or transformation, is able to convert exo-1-aminopyrrolizidine (1-AP) to exo-1-acetamido-pyrrolizidine (AcAP).

### Claim 25 (depends on 24)

The host cell of claim 24 wherein the host cell prior to modification or transformation, has been pre-selected for the ability to convert 1-AP to AcAP.

### Claim 26 (depends on 20)

The host cell of claim 20 wherein the host cell is transformed or modified to comprise at least the polynucleotides of i), ii), iii), v) and vii).

### Claim 27 (depends on 20)

The host cell of claim 20 wherein the host cell is not transformed or modified to comprise the polynucleotide of vi).

### Claim 28 (depends on 20)

The host cell of claim 20 wherein the host cell is not transformed or modified to comprise the polynucleotide of viii).

### Claim 29 (depends on 20)

A method for producing a host cell that produces at least one loline alkaloid or precursor thereof, the method comprising modifying or transforming a host cell to comprise at least one polynucleotide as defined in claim 20.

### Claim 30 (depends on 29)

The method of claim 29 wherein the host cell produces more of at least one loline alkaloid, than does a control cell, as a result of the host cell being transformed or modified to comprise the at least one polynucleotide.

### Claim 31 (depends on 29)

The method of claim 29 wherein the host cell is tolerant of endogenous (3-amino-3-carboxypropyl) proline (ACPP) production.

### Claim 32 (depends on 29)

The method of claim 29 further comprising the step of pre-selecting the host cell for tolerance to cellular ACPP.

### Claim 33 (depends on 29)

The method of claim 29 wherein the host cell prior to modification or transformation, is able to convert exo-1-aminopyrrolizidine (1-AP) to exo-1-acetamido-pyrrolizidine (AcAP).

### Claim 34 (depends on 29)

The method of claim 29 wherein the host cell prior to modification or transformation, has been pre-selected for the ability to convert 1-AP to AcAP.

### Claim 35 (depends on 29)

The method of claim 29 further comprising the step of pre-selecting the host cell for said ability to convert 1-AP to AcAP.

### Claim 36 (depends on 29)

The method of claim 29 wherein the host cell is transformed or modified to comprise at least the polynucleotides of i), ii), iii), v) and vii).

### Claim 37 (depends on 1)

A method for producing at least one loline alkaloid or a precursor thereof, the method comprising culturing the host cells of claim 1 under conditions conducive to the production of the at least one loline alkaloid or precursor thereof, by the host cells.

### Claim 38 (depends on 37)

The method of claim 37 wherein the host cell produces at least one loline alkaloid.
